Chlorpheniramine maleate and Infusion related reaction - a phase IV clinical study of FDA data
Infusion related reaction is found among people who take Chlorpheniramine maleate, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Chlorpheniramine maleate and have Infusion related reaction. It is created by eHealthMe based on reports of 4,892 people who have side effects when taking Chlorpheniramine maleate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,892 people reported to have side effects when taking Chlorpheniramine maleate.
Among them, 153 people (3.13%) have Infusion related reaction.
What is Chlorpheniramine maleate?
Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. eHealthMe is studying from 5,231 Chlorpheniramine maleate users for its effectiveness, alternative drugs and more.
What is Infusion related reaction?
Infusion related reaction is found to be associated with 1,710 drugs and 1,212 conditions by eHealthMe.
Number of Chlorpheniramine maleate and Infusion related reaction reports submitted per year:
Time on Chlorpheniramine maleate when people have Infusion related reaction *:
Gender of people who have Infusion related reaction when taking Chlorpheniramine maleate*:
Age of people who have Infusion related reaction when taking Chlorpheniramine maleate *:
Common drugs people take besides Chlorpheniramine maleate *:
Common side effects people have besides Infusion related reaction *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Chlorpheniramine maleate and have Infusion related reaction?Check whether Infusion related reaction is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Infusion related reaction and when was it recovered:
Expand to all the drugs that have ingredients of chlorpheniramine maleate:
Alternative drugs to, pros and cons of Chlorpheniramine maleate:
- Chlorpheniramine maleate (5,231 reports)
Common Chlorpheniramine maleate side effects:
Browse all side effects of Chlorpheniramine maleate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Infusion related reaction treatments and more:
- Infusion related reaction (57,417 reports)
COVID vaccines that are related to Infusion related reaction:
- Infusion related reaction in Moderna COVID Vaccine
- Infusion related reaction in Pfizer BioNTech Covid Vaccine
- Infusion related reaction in Johnson and Johnson Covid Vaccine
Common drugs associated with Infusion related reaction:
All the drugs that are associated with Infusion related reaction:
- Infusion related reaction (1,710 drugs)
Common conditions associated with Infusion related reaction:
All the conditions that are associated with Infusion related reaction:
- Infusion related reaction (1,212 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on chlorpheniramine maleate (the active ingredients of Chlorpheniramine maleate) and Chlorpheniramine maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Plegridy and Acrodynia - a second ago
- Robaxin and Glomerular Filtration Rate Decreased - 3 seconds ago
- Multiple Sclerosis and Naevus Haemorrhage - 5 seconds ago
- Methimazole and Muscle Twitching - 14 seconds ago
- Sucralfate and Calcium Carbonate drug interaction - 14 seconds ago
- Nitrofurantoin and Left Ventricular Hypertrophy - 15 seconds ago
- Sotret and Menstruation Irregular - 22 seconds ago
- Rasuvo and Xanax drug interaction - 22 seconds ago
- Tamiflu and Mania Aggravated - 23 seconds ago
- Durezol and Posterior Capsule Opacification - 24 seconds ago